In the present study, we found that c‐Met was markedly upregulated in sorafenib‐resistant HCC cells, and sorafenib exposure increased the production of HGF and phosphorylation of c‐Met, leading to the activation of Akt and ERK pathways. The gene discussed is MET; the disease is hepatocellular carcinoma.